Clinical Trial Update: Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on second-line therapies for Pneumocystis jirovecii pneumonia, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumocystis Jirovecii Pneumonia

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Pneumocystis, Pneumocystis Infection | Phase 4 | Status: NOT_YET_RECRUITING